ARG40929

anti-Kininogen 1 antibody

anti-Kininogen 1 antibody for Western blot and Human

Overview

Product Description Rabbit Polyclonal antibody recognizes Kininogen 1
Tested Reactivity Hu
Tested Application WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name Kininogen 1
Antigen Species Human
Immunogen Recombinant protein corresponding to Q19-N210 of Human Kininogen 1.
Conjugation Un-conjugated
Alternate Names Williams-Fitzgerald-Flaujeac factor; Kallidin II; High molecular weight kininogen; KNG; Fitzgerald factor; Alpha-2-thiol proteinase inhibitor; BDK; BK; Kininogen-1; HMWK; Kallidin I; Ile-Ser-Bradykinin

Application Instructions

Application Suggestion
Tested Application Dilution
WB1:500 - 1:2000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Affinity purification with immunogen.
Buffer 0.2% Na2HPO4, 0.9% NaCl, 0.05% Sodium azide and 5% BSA.
Preservative 0.05% Sodium azide
Stabilizer 5% BSA
Concentration 0.5 mg/ml
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 3827 Human KNG1

Swiss-port # P01042 Human Kininogen-1

Gene Symbol KNG1
Gene Full Name kininogen 1
Background This gene uses alternative splicing to generate two different proteins- high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK). HMWK is essential for blood coagulation and assembly of the kallikrein-kinin system. Also, bradykinin, a peptide causing numerous physiological effects, is released from HMWK. Bradykinin also functions as an antimicrobial peptide with antibacterial and antifungal activity. In contrast to HMWK, LMWK is not involved in blood coagulation. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2014]
Function (1) Kininogens are inhibitors of thiol proteases; (2) HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII; (3) HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes; (4) the active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects: (4A) influence in smooth muscle contraction, (4B) induction of hypotension, (4C) natriuresis and diuresis, (4D) decrease in blood glucose level, (4E) it is a mediator of inflammation and causes (4E1) increase in vascular permeability, (4E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (4F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action); (5) LMW-kininogen inhibits the aggregation of thrombocytes; (6) LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting. [UniProt]
Cellular Localization Secreted, extracellular space. [UniProt]
Calculated MW 72 kDa
PTM Bradykinin is released from kininogen by plasma kallikrein.

Hydroxylation of Pro-383 occurs prior to the release of bradykinin.

Phosphorylated by FAM20C in the extracellular medium.

N- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans. [UniProt]

Images (1) Click the Picture to Zoom In

  • ARG40929 anti-Kininogen 1 antibody WB image

    Western blot: 40 µg of U87, 40 µg of MCF7, 40 µg of SKOV, 40 µg of SW620, 40 µg of COLO320 and 50 µg of Human placenta lysates stained with ARG40929 anti-Kininogen 1 antibody at 0.5 µg/ml dilution.